Herbs (Global Traditional) · Ayurveda
Yavani (Hyoscyamus niger) (Hyoscyamus niger)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Yavani (Hyoscyamus niger) is an Ayurvedic herb containing tropane alkaloids including scopolamine and atropine that block acetylcholine receptors. This anticholinergic mechanism produces sedative, antispasmodic, and analgesic effects in traditional medicine applications.
Yavani (Hyoscyamus niger), also known as black henbane or Khurasani Ajwain, is an annual or biennial herb from the Solanaceae family native to Europe and Asia, particularly found in the western Himalayas at elevations of 2,700-3,700 meters. The whole plant is used medicinally, with seeds and leaves being the primary sources, traditionally prepared as powdered seeds containing tropane alkaloids.
The research dossier reveals a complete absence of human clinical trials, RCTs, or meta-analyses for Hyoscyamus niger. All available evidence comes from traditional use contexts and theoretical pharmacological properties based on its anticholinergic alkaloid content, with no PubMed citations provided for human studies.
Traditional dosage ranges from 125-500 mg of powdered seeds for pain, spasms, or sedation, though no clinical studies validate these amounts. No standardization for alkaloid content (hyoscyamine/scopolamine percentage) is established. Due to its classification as Upvisha (poisonous) in Ayurveda, extreme caution is required. Consult a healthcare provider before starting any new supplement.
Hyoscyamus niger (Henbane) is not consumed as a food or nutritional supplement due to its significant toxicity; therefore, a standard nutritional profile (macronutrients, fiber, vitamins, minerals) is not clinically relevant. Its pharmacological importance lies entirely in its bioactive alkaloid content. **Key Bioactive Compounds:** • **Hyoscyamine** — primary tropane alkaloid, typically 0.04–0.16% of dry leaf weight; acts as a potent anticholinergic/parasympatholytic agent. • **Scopolamine (Hyoscine)** — second major tropane alkaloid, approximately 0.01–0.06% of dry leaf weight; responsible for sedative and antiemetic properties. • **Atropine** — present in smaller quantities (racemic form of hyoscyamine), arising partly through racemization during extraction; concentration variable, usually <0.05%. • **Minor alkaloids** — traces of tropine, cuscohygrine, and other tropane derivatives. • **Flavonoids** — including rutin and quercetin glycosides in minor concentrations (~0.1–0.5%), contributing modest antioxidant activity. • **Volatile oils** — present in trace amounts in seeds and leaves, not well characterized quantitatively. • **Fatty acids (seeds)** — seeds contain approximately 15–25% fixed oil, predominantly linoleic acid (~55–65%), oleic acid (~20–25%), and palmitic acid (~8–12%). **Bioavailability Notes:** Tropane alkaloids (hyoscyamine, scopolamine) are rapidly and efficiently absorbed via oral, dermal, and mucosal routes, with high bioavailability (estimated >80% oral absorption for hyoscyamine). They readily cross the blood-brain barrier, particularly scopolamine, which accounts for pronounced CNS effects. **Critical Safety Note:** All parts of the plant are toxic. The therapeutic index is extremely narrow — therapeutic and lethal doses are dangerously close. Alkaloid concentrations vary significantly by plant part (leaves: 0.04–0.16%; seeds: 0.06–0.10%; roots: 0.04–0.08%), growing conditions, and harvest time, making standardized dosing unreliable without pharmaceutical-grade extraction.
Yavani contains tropane alkaloids including scopolamine, atropine, and hyoscyamine that competitively block muscarinic acetylcholine receptors in the central and peripheral nervous systems. This anticholinergic action reduces smooth muscle contractions, decreases glandular secretions, and produces sedative effects by interfering with cholinergic neurotransmission. The alkaloids also interact with GABA receptors, contributing to the plant's traditional calming properties.
No modern clinical trials have evaluated Yavani's therapeutic effects in humans. Traditional Ayurvedic texts describe its use for pain, muscle spasms, and sleep disorders, but these applications lack scientific validation. The plant's alkaloid content has been studied analytically, confirming the presence of bioactive tropane compounds. Given the potent nature of its alkaloids and potential toxicity, clinical research would be necessary to establish safety and efficacy profiles.
Yavani contains toxic tropane alkaloids that can cause serious adverse effects including hallucinations, delirium, seizures, and respiratory depression at higher doses. The plant may interact dangerously with anticholinergic medications, sedatives, and drugs affecting the nervous system. It is contraindicated during pregnancy and breastfeeding due to alkaloid toxicity. Medical supervision is essential before any use, as the therapeutic window between beneficial and toxic doses is extremely narrow.
